Lee, Danner & Bass’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$720K Buy
600
+4
+0.7% +$4.09K 0.04% 174
2026
Q1
$548K Hold
596
0.03% 183
2025
Q4
$641K Sell
596
-30
-5% -$28.7K 0.05% 162
2025
Q3
$478K Buy
626
+31
+5% +$23.1K 0.03% 178
2025
Q2
$464K Buy
595
+10
+2% +$7.77K 0.04% 172
2025
Q1
$483K Buy
585
+26
+5% +$21.6K 0.04% 169
2024
Q4
$432K Buy
559
+65
+13% +$53.8K 0.03% 179
2024
Q3
$438K Hold
494
0.03% 177
2024
Q2
$447K Buy
+494
New +$395K 0.03% 172
2023
Q4
$288K Buy
494
+11
+2% +$6.42K 0.02% 189
2023
Q3
$259K Hold
483
0.02% 190
2023
Q2
$227K Buy
+483
New +$203K 0.02% 192

Other funds holding LLY

Lee, Danner & Bass's LLY Position: Q2 2026 in Review

Lee, Danner & Bass increased its Eli Lilly (LLY) stake by 0.67% in Q2 2026, buying an estimated $4.09K and bringing the position to 600 shares worth $720K. The position accounts for 0.04% of the portfolio, ranked #174.

Lee, Danner & Bass first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. 1,654 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Lee, Danner & Bass held 600 shares of Eli Lilly worth $720K as of Q2 2026.
  • Lee, Danner & Bass bought 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
  • Eli Lilly made up 0.04% of Lee, Danner & Bass's portfolio in Q2 2026, its #174 holding.
  • Lee, Danner & Bass first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
  • 1,654 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Lee, Danner & Bass's 13F filing for Q2 2026, filed 21 Jul 2026.